Home/Pipeline/E1000 Dx Digital Pathology Solution

E1000 Dx Digital Pathology Solution

Cancer Diagnostics (Primary Diagnosis)

ApprovedActive

Key Facts

Indication

Cancer Diagnostics (Primary Diagnosis)

Phase

Approved

Status

Active

Company

Epredia

About Epredia

Epredia, a subsidiary of PHC Holdings Corporation, is a commercial-stage company focused on the diagnostics and medical devices sectors, specifically in anatomic pathology. It offers a comprehensive portfolio including tissue processors, slide printers, and the FDA-cleared E1000 Dx Digital Pathology Solution. Founded in 2019, the company operates globally from its U.S. headquarters, serving as a critical infrastructure provider for cancer diagnostic workflows.

View full company profile

Therapeutic Areas

Oncology